Assessment of symptoms, quality of life and associated costs in a one-month follow-up of cancer patients with breakthrough pain: The IMDI Study
<p>Purpose: Breakthrough Pain (BTP) observed in up to 66% of cancer patients, is more common in patients with advanced cancer stages and is usually associated with a poor prognosis.</p><p>The objective of this study was to evaluate the quality of life and control of associated symp...
Gorde:
Egile Nagusiak: | Concepción Pérez (Egilea), Antonio Javier Jiménez-López (Egilea), Almudena Sanz-Yagüe (Egilea), Begoña Soler-López (Egilea) |
---|---|
Formatua: | Liburua |
Argitaratua: |
Open Journal of Pain Medicine - Peertechz Publications,
2020-01-13.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak
-
IMDIS. A Teaching Tool for Air Pollution Dispersion Modelling
nork: Salcedo, Romualdo
Argitaratua: (2020) -
Observational study to analyse the opioid titration process in the treatment of breakthrough pain of cancer patients in clinical practice
nork: Lara Iglesias-Docampo, et al.
Argitaratua: (2019) -
Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets
nork: Jordi Guitart, et al.
Argitaratua: (2019) -
Consensus statement on the management of breakthrough cancer pain: Assessment, treatment and monitoring recommendations
nork: María Dolores López Alarcón, et al.
Argitaratua: (2019) -
Breakthroughs in women's health for treating vasomotor symptoms
nork: Peng-Hui Wang, et al.
Argitaratua: (2024)